Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

November 18, 2020
Open Access

Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apart

Jeffry D ShearerVladimir Savransky
December 29, 2020
Case Report
Open Access

Cowpox: How dangerous could it be for humans? Case report

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Dagny C KrankowskaJacek P Szaflik
November 22, 2020
Open Access

Control and Prevention of Anthrax, Texas, USA, 2019

Emerging Infectious Diseases
Tom SidwaKate Hendricks
December 30, 2020
Open Access

TaqMan Assays for Simultaneous Detection of Bacillus anthracis and Bacillus cereus biovar anthracis

Diansy ZinckeJason K Blackburn
December 19, 2020

Acute generalized exanthematous pustulosis in children and adolescents in Singapore: A ten-year retrospective review

Pediatric Dermatology
Elis Yuexian Lee, Mark Jean Aan Koh
November 24, 2020
Open Access

MAPt: A Rapid Antibiotic Susceptibility Testing for Bacteria in Environmental Samples as a Means for Bioterror Preparedness

Frontiers in Microbiology
Ronit Aloni-GrinsteinShahar Rotem
November 26, 2020
Open Access

Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters

BioRxiv : the Preprint Server for Biology
Qingmei JiaMarcus A Horwitz
November 22, 2020
Open Access

Outbreak of Anthrax Associated with Handling and Eating Meat from a Cow, Uganda, 2018

Emerging Infectious Diseases
Esther KisaakyeBao-Ping Zhu
December 3, 2020
Open Access

The nucleotide messenger (p)ppGpp is a co-repressor of the purine synthesis transcription regulator PurR in Firmicutes

BioRxiv : the Preprint Server for Biology
B. W. AndersonJue D. Wang
December 22, 2020
Open Access

Analyzing In Silico the Relationship Between the Activation of the Edema Factor and Its Interaction With Calmodulin

Frontiers in Molecular Biosciences
Irène PitardThérèse E Malliavin
November 23, 2020

Novel spore lytic enzyme from a Bacillus phage leading to spore killing

Enzyme and Microbial Technology
Yajuan FuMeiying Gao
December 1, 2020

Assembly and Function of the Anthrax Toxin Protein Translocation Complex

Sub-cellular Biochemistry
Robert C Liddington
November 21, 2020
Open Access

Complete Genome Sequence of an Environmental Bacillus cereus Isolate Belonging to the Bacillus anthracis Clade

Microbiology Resource Announcements
Leonid M IrengeJean-Luc Gala

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

© 2021 Meta ULC. All rights reserved